ABSTRACT. Four commonly used pyrethroids (permethrin, bifenthrin, ethofenprox, and fenpropathrin) were orally administered to SpragueDawley rats for 5 days to study their effects on the liver cytochrome P450 (CYP) activities. Also Michaelis-Menten kinetics of the metabolic reactions catalyzed by liver CYPs were examined after adding these pyrethroids to the assay system to investigate their possible inhibitory effects on liver CYPs activities. These reactions included ethoxyresorufin O-deethylation, tolbutamide hydroxylation, bufuralol 1'-hydroxylation, and midazolam 4-hydroxylation, for CYP1A, 2C, 2D, and 3A activities, respectively. Results showed that oral administration of bifenthrin and ethofenprox highly induced CYP1A. The most potent inhibitors for CYP1A were fenpropathrin and cis-permethrin with K i values of 3.71 & 3.87 M, respectively. CYP2D was slightly inhibited by both of fenpropathrin and cispermethrin (K i values were 307.32 & 632.23 M, respectively). On the other hand, none of CYP2C or 3A was inhibited by the tested pyrethroids. Since CYP1A may relate to biotransformation of many chemicals to reactive metabolites, bifenthrin and ethofenprox may potentiate mutagenicity of the chemicals through their inducing effects on CYP 1A. As permethrin and fenpropathrin were potent inhibitor for CYP1A, they may result in substantial accumulation of some chemicals. The resultant accumulation may lead to fatal toxicities in some case.
Cytochrome P450 isoenzymes (CYPs) are superfamily of haemoprotein enzymes found on the membranes of smooth endoplasmic reticulum. These enzymes are responsible for catalyzing oxidation of large number of xenobiotics and, therefore, have important roles in detoxication of many chemicals. On the other hand, some chemicals are converted to reactive metabolites indicating mutagenic properties. Benzo(a)pyrene and acetoaminophen are well-known examples of such chemicals. In human, CYP1A1 and 3A4 are involved in the biotransformation of benzo(a)pyrene and acetoaminophen to reactive metabolites, respectively [3, 10] . Since it is impossible to avoid chemical use and, therefore, to avoid chemical exposure, the alteration in CYP activities may bring harmful effects on not only our health, but also environmental lives. Because of this fact, effects of drugs on CYP activities have been well established [12, 23] . Those of other classes of xenobiotics, however, are not established well, although their toxicological profiles, including general toxicity, developmental and reproductive toxicity, genetic toxicity and carcinogenicity, have been well investigated.
Pesticides are a class of chemicals that we are frequently exposed. Of pesticides, pyrethroids are used in a wide array of indoor and outdoor applications due to their selective toxicity against pests rather than mammals [25] . Their extensive applications include medicinal, veterinary, and agricultural usages. Pyrethroids are easily converted to nontoxic derivatives through hydrolysis in mammalian species. In insects, however, this hydrolytic activity is quite low [1, 6, 7, 16] .
Many of currently-used pyrethroids are recognized to be relatively safe, based on their toxicological profiles. However, if they have the potential to alter CYP activities through inhibitory or inducing effects, they may alter biotransformation of many other chemicals with which we are exposed. In addition, biotransformation of endogenous substances may be altered. Although such alteration may result in harmful effects, information about effects of pyrethroids on CYP activities is lacking. Therefore, the primary aim of the present study was to characterize the effects of several pyrethroids, including permethrin, bifenthrin, ethofenprox, and fenpropathrin, on CYP activities in rats.
MATERIALS AND METHODS

Animals:
Total of 60 male Sprague-Dawley rats were obtained from Japan Cler Inc. (Tokyo, Japan) and allowed to acclimatize to their environment for at least 1 week prior to the experiment. At the start of the experiment, their age and body weight were 9 weeks and 270-320 g, respectively. The animals were housed in stainless-steel cages at a temperature of 25C and humidity of 55-70% with 12-hr lightdark cycle and allowed free access to water and food. The experiments in this study were conducted in accordance with the guidelines for the care and use of laboratory animals and approved by the committee of animal experiment, Tokyo University of Agriculture and Technology. Experimental design, Effects of pyrethroids on hepatic CYP activities after oral administration: Effects of permethrin, bifenthrin, ethofenprox and fenpropathrin on activities of CYP1A, 2C, 2D and 3A subfamilies were examined in rats. For each tested pyrethroids, fifteen rats were used after being divided into three groups (five of each); first group was served as control and administered corn oil (vehicle) for 5 days using a stomach tube, the other two groups were orally administered a pyrethroid for 5 days at one-tenth or one-thirtieth of their LD 50 , or 30 and 100 mg/kg when LD 50 s are more than 1,000 mg/kg. As a result, used doses were as followings; 20 and 60 mg/kg for permethrin [29] , 1.7 and 5.1 mg/kg for bifenthrin [31] , 30 and 100 mg/kg for ethofenprox [13] , and 2.2 and 6.6 mg/kg for fenpropathrin [13] . Permethrin was administered with a mixture of cisand trans-permethrin (25:75, w/w), because only the mixtures (25:75~40:60, w/w) are commercially available as an insecticide. After 24 hr of the final dose, rats were killed under a deep anesthesia with diethyl ether, and the liver was isolated and instantly perfused with ice-cold buffer (1.15% KCl, 0.2 mM EDTA-2Na, 0.1 mM dithiothreitol, 0.1 mM phenyl methyl sulphonyl fluoride, and 20% glycerol) till the efflux perfusion buffer was blood free. Then, the liver was cut into pieces and stored at -80C until preparation of microsomes.
Inhibition study: In this study inhibitory effects of 4 pyrethroids on CYP1A, 2C, 2D, and 3A activities were also examined using the liver microsomes obtained from the control groups of the first experiment. Each pyrethroid was dissolved in dimethyl sulfoxide then added to the enzyme assay system in a volume of 10 l. The final concentrations of pyrethroids ranged from 3-1,000 M in assay system.
Preparation of hepatic microsomes:
The microsomal fractions were prepared from the liver specimens using the differential centrifugation method described by Van der Hoeven and Coon [28] . The obtained microsomal suspension was stored at -80C until being used. Protein concentrations in each microsomal sample were determined spectrophotometrically using protein assay kits and bovine serum albumin [4] .
Enzyme-assays: The activities of CYP1A, 2C, 2D, and 3A were examined by using ethoxyresorufin O-deethylation (EROD), tolbutamide hydroxylation (TBH), bufuralol 1'-hydroxylation (BLH), and midazolam 4-hydroxylation (MDZH), respectively. The reaction proceeded at 37C in a reaction mixture that contained NADPH generating system [50 mM phosphate buffer (pH 7.4), 0.5 mM -NADP + , 5 mM glucose-6-phosphate, 1.5 U/ml glucose 6-phosphate dehydrogenase and 5 mM MgCl 2 ], liver microsomes (0.03 mg/ml for EROD and 0.4 mg/ml for other reactions), and a substrate at various concentrations in a total volume of 0.25 ml, except for EROD where total volumes of 1 ml was used. A 5-min pre-incubation step at 37C was performed before the reaction was started by the addition of substrate.
Determination of CYP1A activity: The metabolite of ethoxyresorufin, resorufin, was measured using the fluorometric method [5] . The concentration of ethoxyresorufin in the assay system was 2 M, which is approximately 10-fold higher than the K m value (0.227 M) reported in rats [14] . In the inhibition study, concentrations of ethoxyresorufin in the assay system ranged from 0.82 to 4.1 M. Reactions were terminated by addition of 3 ml of methanol 15 min after the substrate was added, followed by placement on ice for 5 min. After centrifugation at 2,000 g for 5 min, 1 ml of the resulting supernatant was transferred to a clean test tube, diluted with 4 ml of methanol, and applied to a spectrofluorometer (RF-1500; Shimadzu Corporation, Kyoto, Japan). Excitation and emission wavelengths were set at 550 and 586 nm, respectively. The detection limit was 0.05 nM at a signal-to-noise ratio of 3. The recovery of resorufin was 103  6% at 20 nM (n=4). The intraday CV values were 3.7 and 5.1% at 20 and 400 nM (n=4), respectively. The interday CV values ranged from 3.4 to 6.4% and 1.6 to 5.1% at 20 and 400 nM respectively (3 days, 4 determinations/day).
Determination of CYP2C activity: The metabolite of tolbutamide, hydroxytolbutamide, was measured using HPLC with UV detection [22] . The concentration of tolbutamide in the assay system was 10 mM, which is approximately 5-fold higher than the K m value (1.91 mM) reported in rats [11] . In the inhibition study, concentrations of tolbutamide in the assay system ranged from 1 to 10 mM. After the addition of tolbutamide, the assay system was incubated for 30 min, and the reactions were stopped by adding 0.15 M phosphoric acid (0.25 ml). Thirty microliters of chlorpropamide solution (10 g/ml) were added as an internal standard. The samples were mixed with 3 ml of diethyl ether. After centrifugation at 2,000 g for 5 min, the upper organic layer was transferred to a clean pear-shaped flask and evaporated until dryness under reduced pressure. The residue was reconstituted with 500 l of mobile phase, then 50 l of the solution was injected into a reversed-phase column (TSK-gel ODS-120, 4.6  250 mm; TOSOH Co., Tokyo, Japan). The column effluent was monitored by UV absorbance at 230 nm. The mobile phase consisted of 50 mM phosphate buffer (pH 4.3) and acetonitrile (75:25, v/v). The flow rate was 1 ml/ min. The recoveries of hydroxytolbutamide and chlorpropamide were 91.2  1.2 and 96.2  3.7% at 1 and 10 g/ml respectively (n=4). The intra-day CV values were 1 and 4% at 0.1 and 1 g/ml, respectively (n=4). The inter-day CV values ranged from 1.9 to 8.2% and 1.3 to 6.3% at 0.1 and 1 g/ml, respectively (3 days, 4 determinations/day), with the limit of quantification of 20 ng/ml at a signal-to-noise ratio of 3.
Determination of CYP2D activity: The metabolite of bufuralol, 1'-hydroxybufuralol, was analyzed using HPLC with fluorometric detection [18] . The concentration of bufuralol in the assay system was 50 M, which is approximately 10-fold higher than the K m value (6.4 M) reported in rats [8] . In the inhibition study, concentrations of bufuralol in the assay system ranged from 4 to 134 M.
After the addition of bufuralol, the assay system was incubated for 10 min, and reaction was stopped by the addition of 30 l of 60% perchloric acid. The denatured protein was precipitated by centrifugation at 10,000 g for 2 min, then 50 l of the supernatant was injected to the ODS column. The mobile phase consisted of 1 mM perchloric acid and acetonitrile (65:35, v/v). The flow rate was 1.0 ml/min. Excitation and emission wavelengths were 252 and 302 nm, respectively. Recovery of the metabolite was 91.4  3.0% at 0.1 g/ml (n=4). The intraday CV values were 1.8 and 2.1% at 0.1 and 1 g/ml, respectively (n=4). The inter-day CV values ranged from 1.9 to 7.9% and 1.9 to 3.1% at 0.1 and 1 g/ml, respectively (3 days, 4 determinations/day), with detection limit of 5 ng/ml at a signal-to-noise ratio of 3.
Determination of CYP3A activity: The metabolite of midazolam, 4-hydroxymidazolam, was determined using HPLC with UV-detection as described by Kuroha et al. [19] . The concentration of midazolam in the assay system was 214 M, which is approximately 10-fold higher than the K m (22 M) reported in rats [17] . In the inhibition study, concentrations of midazolam in the assay system ranged from 15 to 214 M. After the addition of midazolam, the mixture was incubated for 10 min, and the reaction was stopped by the addition of 0.25 ml of acetonitrile and placed on ice for 3 min. After centrifugation at 10,000 g for 2 min, the resulting supernatant was applied to the ODS column. The mobile phase consisted of 100 mM of acetate buffer (pH 4.7), acetonitrile and methanol (59.4:35:5.6, v/v/v). Column effluent was monitored by UV absorbance at 254 nm. The flow rate was 1 ml/min. The detection limit of 4-hydroxymidazolam was 2.5 ng/ml, at a signal-to-noise ratio of 3. The recovery of 4-hydroxymidazolam was 102  3.4% at 1 g/ml (n=4). The intra-day CV values were 1 and 3.9% at 0.1 and 1 g/ml, respectively (n=4). The inter-day CV values ranged from 0.2 to 0.5% and 2.6 to 8.5% at 0.1 and 1 g/ml, respectively (3 days, 4 determinations/day).
Michaelis-Menten kinetic analysis:
The following equation was applied to the relation between reaction velocities (V) and substrate concentrations (S) to analyze the enzyme kinetics;
In this equation, V max and K m represent maximal reaction velocity and Michaelis-Menten constant, respectively.
Since all the tested pyrethroids inhibited the enzymes reactions in a noncompetitive manner, the kinetic profile of enzyme inhibition was expressed by the following equation; Where K i is the inhibition constant, and I is the inhibitor concentration. The two curves, which were obtained with or without inhibitors in each reaction, were simultaneously analyzed using the fitting program MULTI created by Yamaoka et al. [30] to calculate V max , K m and K i .
Statistical analysis: Data of treated groups were compared with those of control group to show the significant induction of hepatic CYPs by orally administered pyrethroids. After confirming equal variances by Bartlett's test, ANOVA was done. If ANOVA showed statistical differences, the differences in averages among groups were analyzed by Dunnett's multiple comparison. If unequal variances were obtained from Bartlett's test, the nonparametric Kruskal-Wallis test was used for comparison between treatment and control group. Significance between groups was accepted when P<0.05. Figure 1 shows the effects of several pyrethroids on the hepatic microsomal activities of EROD, TBH, BLH and MDZH after oral administration of each pyrethroid for 5 consecutive days. EROD activity was significantly higher in both of bifenthrin and ethofenprox treated groups than those in control group. On the other hand, permethrin or fenpropathrin administration had no effect on any of the examined CYP activities.
RESULTS
Effects of oral pyrethroids on hepatic CYP activities:
Inhibition study: Figures 2 to 5 show Michaelis-Menten kinetics of the EROD, TBH, BLH and MDZH with or without pyrethroids in the assay system. Table 1 shows kinetic parameters including V max , K m and inhibition constant (K i ) Fig. 2 . Michaelis-Menten kinetics of ethoxyresorufin O-deethylation (EROD) in hepatic microsomes from rats. The solid curves represent the theoretical metabolic rates calculated using V max and K m values showed in Table 1 . Closed and opened circles represent the observed metabolic rates (mean  SD) in the presence or absence of pyrethroids, respectively.
for each reaction. In the reaction of EROD, cis-permethrin and fenpropathrin showed relatively strong inhibition with For the other reactions, inhibitory effects of the pyrethroids were quite small with high K i values as shown in Table 1 .
DISCUSSION
In this study, we investigated the effects of 5 days oral treatment of several pyrethroids, including permethrin, bifenthrin, ethofenprox, and fenpropathrin, on the hepatic CYP activities in rats. Permethrin has been known to be a CYP2B inducer [9] . This study, therefore, included this pesticide. As a result, it was shown that bifenthrin and ethofenprox significantly induced CYP1A. On the other hand, permethrin and fenpropathrin did not induce any CYPs examined.
Induction of hepatic CYP enzymes may adversely affect the body. One of undesirable effects is the accumulation of the reactive metabolites of exposed xenobiotics which could be carcinogenic [21] . High doses of pyrethrins have been shown to increase the incidence of hepatocellular adenoma in female rats and to increase the combined incidence of thyroid gland follicular cell adenomas and/or carcinomas in both sexes [26] . Recently, CYP inducing effects of some pyrethroids have been reported relating to their cytotoxicities and genotoxicities, although there had been only few reports on pyrethroids related CYP induction. Das et al. [9] The solid curves represent the theoretical metabolic rates calculated using V max and K m values showed in Table 1 . Closed and opened circles represent the observed metabolic rates (mean  SD) in the presence or absence of pyrethroids, respectively. demonstrated permethrin and deltamethrin induced CYP1A, 2B and 3A in human hepatocyte and found cytotoxicities in HepG2 cells. Price et al. [24] reported significant induction of CYP2B and 3A by pyrethrins in rat and human hepatocytes and suggested that induction may be associated with the liver and thyroid gland tumor. Furthermore, metofluthrin was found to induce CYP2B in rat and human hepatocytes [15] . Such induction was suggested to be linked to hepatic tumor observed in rats after a long term treatment with this pesticide at a high dose [10] . Based on our results, bifenthrin and ethofenprox may result in hepatic tumor, if they administered at high doses like permethrin and deltamethrin. Although enzyme inhibition is other major concerns in toxicology, such information is very limited [2] . We, therefore, examined also possible inhibitory effects of pyrethroids on the activities of CYP1A, 2C, 2D, and 3A. Michaelis-Menten kinetic analysis indicated that cis-permethrin and fenpropathrin are a potent, noncompetitive inhibitor for CYP1A, based on K i values (3.87  0.28 M for cis-permethrin and 3.71  0.221 M for fenpropathrin) and double reciprocal plots. However, their inhibitory effects on other CYP activities were extremely low or negligible. On the other hand, ethofenprox, bifenthrin and transpermethrin caused only slight inhibition in CYP1A activities with relatively high K i values (582  56.9 for ethofenprox, 444  24.3 for bifenthrin and 142  8.78 M for transpermethrin) and negligible inhibition in CYP2C and 3A activities. From the point of enzyme inhibition, fenpropathrin may results in harmful effects through their inhibitory effects on CYP1A activities, because CYP1A is responsible for detoxication of many pollutants including arylhydrocar- Fig. 4 . Michaelis-Menten kinetics of tolbutamide hydroxylation (TBH) in hepatic microsomes from rats. The solid curves represent the theoretical metabolic rates calculated using V max and K m values showed in Table 1 . Closed and opened circles represent the observed metabolic rates (mean  SD) in the presence or absence of pyrethroids, respectively.
bons [27] .
Although trans-permethrin is not a potent inhibitor for CYP1A, permethrin as a commercial formulation may be also harmful, because it contains cis-permethrin at most 40%. Bifenthrin and ethofenprox may be not so harmful.
In this study, estimated K m values were higher than those previously reported in rats [32] ; this was due to dimethyl sulfoxide used to dissolve pyrethroids. This might bring a bias in interpretation of K i values. However, we could not find any alternate vehicle for pyrethroids tested here, because they were quite lipid soluble.
In conclusion, bifenthrin and ethofenprox were the inducers of CYP1A. As have been shown in permethrin [9] , the exposure with these pesticides may result in harmful effects on our health and environmental lives through their inducing effects on the CYPs. Fenpropathrin and permethrin were potent inhibitors of CYP1A, these pesticides may also result in harmful effects through the enzyme induction. However, the further study may be required to evaluate these pyrethroids as an environmental pollutant, because the selected doses here and the environmental exposure levels may be different. Table 1 . Closed and opened circles represent the observed metabolic rates (mean  SD) in the presence or absence of pyrethroids, respectively.
